Cargando…

Comprehensive proteomics and platform validation of urinary biomarkers for bladder cancer diagnosis and staging

BACKGROUND: Bladder cancer (BC) is among the most common cancers diagnosed in men in the USA. The current gold standards for the diagnosis of BC are invasive or lack the sensitivity to correctly identify the disease. METHODS: An aptamer-based screen analyzed the expression of 1317 proteins in BC com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vanarsa, Kamala, Castillo, Jessica, Wang, Long, Lee, Kyung Hyun, Pedroza, Claudia, Lotan, Yair, Mohan, Chandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074794/ https://www.ncbi.nlm.nih.gov/pubmed/37016361 http://dx.doi.org/10.1186/s12916-023-02813-x

Ejemplares similares

Proteomics in rheumatology: the dawn of a new era
por: Vanarsa, Kamala, et al.
Publicado: (2010)

Urine protein biomarkers of bladder cancer arising from 16-plex antibody-based screens
por: Vanarsa, Kamala, et al.
Publicado: (2021)

Comprehensive aptamer-based screening identifies a spectrum of urinary biomarkers of lupus nephritis across ethnicities
por: Stanley, Samantha, et al.
Publicado: (2020)

Resistin, Elastase, and Lactoferrin as Potential Plasma Biomarkers of Pediatric Inflammatory Bowel Disease Based on Comprehensive Proteomic Screens
por: Louis Sam Titus, Anto Sam Crosslee, et al.
Publicado: (2022)

Quantitative proteomic screening uncovers candidate diagnostic and monitoring serum biomarkers of ankylosing spondylitis
por: Hwang, Mark, et al.
Publicado: (2023)

Author Correction: Comprehensive aptamer-based screening identifies a spectrum of urinary biomarkers of lupus nephritis across ethnicities
por: Stanley, Samantha, et al.
Publicado: (2020)

Exploring urine:serum fractional excretion ratios as potential biomarkers for lupus nephritis
por: Soliman, Samar A., et al.
Publicado: (2022)

Inflammation associated anemia and ferritin as disease markers in SLE
por: Vanarsa, Kamala, et al.
Publicado: (2012)

Editorial: Identifying novel biomarkers in bladder cancer
por: Ecke, Thorsten H., et al.
Publicado: (2023)

Baseline Elevations of Leukotriene Metabolites and Altered Plasmalogens Are Prognostic Biomarkers of Plaque Progression in Systemic Lupus Erythematosus
por: Baig, Sahar, et al.
Publicado: (2022)

Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus
por: Soliman, Samar A., et al.
Publicado: (2022)

Leukocyte Beta-Catenin Expression Is Disturbed in Systemic Lupus Erythematosus
por: Orme, Jacob J., et al.
Publicado: (2016)

Low Dose Epigallocatechin Gallate Alleviates Experimental Colitis by Subduing Inflammatory Cells and Cytokines, and Improving Intestinal Permeability
por: Du, Yong, et al.
Publicado: (2019)

An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer
por: Soria, Francesco, et al.
Publicado: (2018)

Review of the Clinical Approaches to the Use of Urine-based Tumor Markers in Bladder Cancer
por: Clinton, Timothy, et al.
Publicado: (2017)

Predictors of Outcome of Non–Muscle-Invasive and Muscle-Invasive Bladder Cancer
por: Youssef, Ramy F., et al.
Publicado: (2011)

Epigallocatechin-3-Gallate Dampens Non-Alcoholic Fatty Liver by Modulating Liver Function, Lipid Profile, and Macrophage Polarization
por: Du, Yong, et al.
Publicado: (2021)

Comprehensive optimization of urinary exfoliated tumor cells tests in bladder cancer with a promising microfluidic platform
por: Gao, Fengbin, et al.
Publicado: (2022)

Association of Urine sCD163 With Proliferative Lupus Nephritis, Fibrinoid Necrosis, Cellular Crescents and Intrarenal M2 Macrophages
por: Zhang, Ting, et al.
Publicado: (2020)

Predicting disease course in ulcerative colitis using stool proteins identified through an aptamer-based screen
por: Soomro, Sanam, et al.
Publicado: (2021)

Integrated genomic, proteomic and cognitive assessment in Duchenne Muscular Dystrophy suggest astrocyte centric pathology
por: Wijekoon, Nalaka, et al.
Publicado: (2023)

Molecular Predictors of Complete Response Following Neoadjuvant Chemotherapy in Urothelial Carcinoma of the Bladder and Upper Tracts
por: Tse, Jennifer, et al.
Publicado: (2019)

Current Staging Procedures in Urinary Bladder Cancer
por: Maurer, Tobias, et al.
Publicado: (2013)

Quantitative proteomics identifies and validates urinary biomarkers of rhabdomyosarcoma in children
por: Xu, Na, et al.
Publicado: (2023)

Congenital Dilatation of the Fœtal Urinary Bladder
por: Das, Probodh Chandra
Publicado: (1933)

Shed urinary ALCAM is an independent prognostic biomarker of three-year overall survival after cystectomy in patients with bladder cancer
por: Egloff, Shanna A. Arnold, et al.
Publicado: (2016)

Green Tea Epigallocatechin-3-Gallate Suppresses Autoimmune Arthritis Through Indoleamine-2,3-Dioxygenase Expressing Dendritic Cells and the Nuclear Factor, Erythroid 2-Like 2 Antioxidant Pathway
por: Min, So-Youn, et al.
Publicado: (2015)

Water intake and recurrent urinary tract infections prevention: economic impact analysis in seven countries
por: Zemdegs, Juliane, et al.
Publicado: (2023)

ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus
por: Parodis, Ioannis, et al.
Publicado: (2020)

Metabolomics analysis reveals distinct profiles of nonmuscle‐invasive and muscle‐invasive bladder cancer
por: Sahu, Divya, et al.
Publicado: (2017)

The Urinary Bladder Transcriptome and Proteome Defined by Transcriptomics and Antibody-Based Profiling
por: Habuka, Masato, et al.
Publicado: (2015)

Urinary proteomics and metabolomics studies to monitor bladder health and urological diseases
por: Chen, Zhaohui, et al.
Publicado: (2016)

A comprehensive analysis and annotation of human normal urinary proteome
por: Zhao, Mindi, et al.
Publicado: (2017)

Proteomic analysis of urinary and tissue‐exudative extracellular vesicles to discover novel bladder cancer biomarkers
por: Tomiyama, Eisuke, et al.
Publicado: (2021)

Investigation of Early Protein Changes in the Urinary Bladder Following Partial Bladder Outlet Obstruction by Proteomic Approach
por: Kim, Hyung-Jee, et al.
Publicado: (2005)

Urinary biomarkers of overactive bladder
por: Tian, Xiao-Jun, et al.
Publicado: (2019)

Urinary pro-thrombotic, anti-thrombotic, and fibrinolytic molecules as biomarkers of lupus nephritis
por: Qin, Ling, et al.
Publicado: (2019)

A Comprehensive Approach to Clinical Staging of Bladder Cancer
por: Adamczyk, Przemysław, et al.
Publicado: (2022)

Validation of a Novel Modified Aptamer-Based Array Proteomic Platform in Patients with End-Stage Renal Disease
por: Han, Zhongji, et al.
Publicado: (2018)

Development and Multicenter Case–Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction
por: Salari, Keyan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j2j9ic3h37d383r07bvgk8c5dp